Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 110.90 INR
Change Today -1.35 / -1.20%
Volume 195.9K
ELDP On Other Exchanges
Natl India
As of 7:05 AM 10/6/15 All times are local (Market data is delayed by at least 15 minutes).

elder pharmaceuticals ltd (ELDP) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/10/14 - 187.85
52 Week Low
06/10/15 - 66.60
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

elder pharmaceuticals ltd (ELDP) Related Businessweek News

No Related Businessweek News Found

elder pharmaceuticals ltd (ELDP) Details

Elder Pharmaceuticals Limited manufactures and markets prescription pharmaceutical brands, and surgical and medical devices in India and internationally. The company offers various products in the therapeutic areas of nutraceuticals, anti-infectives, pain management, and life-style disorders. It also provides products in the categories of anti-biotics, CNS, CVS, GI, gynae, antiinflamattory, haematinics, immunomodulators, multivitamin multinutrients, eye-ear drops, respiratory, vascular system, pre pro biotics, woundcare, antiarthritic, musculoskeletal system, paediatric formulations, immune system, anti fungals, and genito urinary system. The company provides its products in various dosage forms, such as tablets, capsules, syrups, injectables, oral rinse, skin creams, and ointments. Elder Pharmaceuticals Limited was incorporated in 1983 and is based in Mumbai, India.

Founded in 1983

elder pharmaceuticals ltd (ELDP) Top Compensated Officers

Chief Executive Officer, Managing Director, W...
Total Annual Compensation: 7.9M
Compensation as of Fiscal Year 2014.

elder pharmaceuticals ltd (ELDP) Key Developments

Elder Pharmaceuticals Consider Sale Of Subsidiaries

Elder Pharmaceuticals Limited (BSE:532322) scheduled a board meeting on September 28, 2015 to consider the proposal for sale of step down overseas subsidiaries. Shares of Elder Pharmaceuticals have surged over 13% at INR 114 on the BSE on the news.

Elder Pharmaceuticals Limited, Board Meeting, Sep 28, 2015

Elder Pharmaceuticals Limited, Board Meeting, Sep 28, 2015. Agenda: To consider the proposal for sale of step down overseas subsidiaries.

Elder Pharmaceuticals May Sell Its Overseas Subsidiaries.

Elder Pharmaceuticals Limited (BSE:532322) said that its board will meet next week to consider sale of Elder Pharmaceuticals's overseas subsidiaries. A meeting of Elder Pharmaceuticals's Board will be held on September 28, 2015, to consider the proposal for sale of step down overseas subsidiaries, Elder Pharma said in a regulatory filing.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ELDP:IN 110.90 INR -1.35

ELDP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $39.89 USD -1.50
Cadila Healthcare Ltd 425.65 INR +9.41
Cipla Ltd/India 664.00 INR +23.90
GlaxoSmithKline PLC 1,307 GBp -6.00
View Industry Companies

Industry Analysis


Industry Average

Valuation ELDP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 0.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELDER PHARMACEUTICALS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at